A pharmacokinetic study to evaluate the piglet as a model for caffeine and theophylline disposition was undertaken in 28 animals who received a 10.0-mg/kg intravenous dose of either methylxanthine, followed by multiple blood sampling over a 24-hour period. Theophylline and caffeine concentrations were quantitated from serum using a microanalytical HPLC technique (coefficient of variability <7% at 0.1-100 mg/1). The influence of postnatal development on drug disposition was examined by dividing the experimental animals into three age groups (newborn, 2 days; perinatal, 4-5 days; infants or young, 15-22 days). Pharmacokinetic parameters were calculated from nonlinear curve fitting of serum concentration vs time data. On the basis of the terminal elimination rate constant (λz) and total clearance (CL) for both theophylline and caffeine, differences were found among the age groups. The apparent volume of distribution (V(z)) for both methyl- xanthines was not found to be different when compared between age groups. Covariance determinations between age and pharmacokinetic parameters revealed linear correlations for V(z) of caffeine and CL for both theophylline and caffeine. In all piglets receiving theophylline, no caffeine was detected in serum during a 24 hr period. Theophylline, however, was detected (0.4 ± 0.2 mg/1 at 11.5 hr) in the four oldest piglets who received caffeine. Similarities between pharmacokinetic parameters for caffeine and theophylline reported for human neonates were found only for newborn piglets. Furthermore, the biotransformation of theophylline to caffeine reported for human neonates was not observed in neonatal piglets.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.